US Politics
The Trump administration is reportedly facing internal resistance from a movement known as “#AltGov,” composed of federal workers opposing the administration’s policies. This group, which communicates through anonymous social media accounts, aims to expose what they perceive as harmful policies. The administration is implementing significant cuts, including the closure of over 120 IRS offices and potential large-scale staff reductions. Elon Musk, overseeing the Department of Government Efficiency, has purportedly threatened job cuts for non-compliance with performance inquiries. Amidst these changes, a potential government shutdown looms as Congress remains divided over funding and downsizing efforts. Critics argue that the #AltGov movement undermines the democratic process, while supporters claim it defends public institutions against perceived authoritarianism.
In a related development, former NIH Director Dr. Francis Collins retired amid allegations of perjury concerning gain-of-function research in Wuhan. President Trump has nominated Dr. Jay Bhattacharya as the new NIH Director, who reportedly aims to reform scientific institutions for greater transparency. Bhattacharya is known for his criticism of COVID-19 lockdowns and co-authorship of The Great Barrington Declaration. Collins’ retirement has sparked debate over the NIH’s role in controversial research, with some viewing it as a shift in U.S. scientific policy.
Economy
The U.S. markets are experiencing a downturn following President Trump’s announcement of 25% tariffs on imports from Mexico and China. The S&P 500 has lost its gains for the year, with the auto industry particularly affected. The tariffs disrupt the North American free-trade zone, impacting car assembly and parts supply. Ford’s CEO has warned of potential harm to profits, jobs, and car prices. Additionally, the AI trade, which has previously boosted stocks, appears to be losing momentum, with Nvidia’s stock falling despite strong earnings. Rising jobless claims further dampen economic confidence, and the Economic Policy Uncertainty Index has reached record levels. Analysts suggest that the tariffs could lead to a drop in bond yields, reflecting broader economic concerns.
Dell Technologies and HP Inc. reported mixed financial results, with both companies noting the impact of the current trade environment on profitability. Dell anticipates strong AI prospects despite a slightly below-expectations revenue outlook, while HP’s revenue beat expectations but profit margins narrowed. Both companies are navigating the challenges posed by tariffs, with Dell highlighting AI expansion and HP noting the negative impact on profitability.
Health
A Texas child reported as having died from measles, may have actually died from pneumonia and RSV after having been given a vaccine for measles while sick, leading to a misinterpretation of the cause of death. This incident highlights ongoing debates about vaccine misinformation and the importance of accurate diagnosis. Health officials emphasize the safety of vaccines but acknowledge the need for proper timing and health assessments before administration.
In other vaccine news, Dr. Joseph Varon has spotlighted concerns about the safety and efficacy of mRNA COVID-19 vaccines, citing potential health issues such as myocarditis and neurological disorders. He argues that mRNA shots are more akin to gene therapy and highlights the need for further investigation before new rollouts. Dr. Varon emphasizes the importance of understanding these issues to avoid repeating past mistakes. However, studies have shown that mRNA vaccines have been instrumental in preventing severe illness, with benefits reportedly outweighing the risks.
Finally, in a separate health-related issue, the FDA’s long-standing ban on DMSO is under scrutiny. Advocates argue that DMSO could transform the management of strokes, heart attacks, and spinal cord injuries. Despite its potential benefits, the FDA’s opposition has limited its use, which some see as a significant failure. Critics of the ban argue that DMSO’s potential merits further investigation, while skeptics point to side effects and the need for more clinical trials.
Geopolitics
After the heated exchange between Presidents Trump and Zelenskyy, Russian President Vladimir Putin has suggested a potential deal with the U.S. regarding rare-earth minerals, claiming that Russia’s reserves surpass those of Ukraine. Putin expressed willingness to collaborate with American partners on capital-intensive projects involving these resources. This offer comes amidst ongoing geopolitical tensions and highlights Russia’s strategic positioning in the global rare-earth market. While the offer could benefit U.S. industries, it raises concerns about deepening economic ties with Russia amid current geopolitical tensions.
Sources
The #AltGov Rebellion: Federal Workers Resist Trump and Musk’s New Administration from Within
A secretive movement known as “#AltGov” has become the epicenter of that rebellion.
Source | Submitted by AaronMcKeon
U.S. Markets Stumble Amid Trump Tariffs and Tech Fatigue: What You Need to Know
Trump Tariffs and Tech Troubles Are Hitting Markets.
Source (Paywalled) | Submitted by bi306b
Is mRNA Technology a Misstep? Dr. Varon Questions Safety and Efficacy of COVID-19 Vaccines
Why is mRNA different? It’s not a true vaccine, but rather a gene therapy.
Source | Submitted by Chris Martenson
Putin Dangles Rare-Earth Mineral Deal to U.S., Claims Russia’s Reserves Outstrip Ukraine’s
Vladimir Putin hints at offering the U.S. a deal on rare-earth minerals, saying Russia has way more than Ukraine.
FDA’s Decades-Long DMSO Ban: A Missed Miracle for Stroke and Spinal Injury Patients?
DMSO is a remarkably safe chemical that protects cells from otherwise fatal stressors (e.g., freezing, burning, shockwaves, ischemia).
Francis Collins Retires Amid Controversy Over Gain-of-Function Research Allegations; Trump Nominates Jay Bhattacharya as NIH Director
Former NIH Director Dr. Francis Collins abruptly retired from the agency on Saturday amid accusations of perjury.
Tragic Texas Case Sparks Vaccine Mislabeling Concerns Amidst Misinformation Debate
Throughout the history of vaccine misinformation in this country one thing remains the same: relabeling other illnesses as the disease for which vaccine hysteria is being whipped up.
In addition to sources submitted by community members, the following were also used in the creation of this report: The Guardian, The Washington Post, The Hill, The New York Times, Science Magazine, Barron’s, CNBC, The Lancet, British Medical Journal, and Reuters.
by aaronmckeon 
